Summary of Purpose
The objectives of this study are to review the safety and efficacy of Actilyse Vial (hereafter referred to as "Actilyse") in post-marketing use for treatment of acute ischemic stroke, through investigating followings; 1. Unknown adverse events (especially serious adverse events) 2. Frequency (Incidence) and trend of adverse events under the actual practice 3. Factors on the safety profile of...Read More →
The following dates are available for this trial. Trial information last updated on 28 August 2014.
|1 Feb 2003||28 Aug 2014||1 Dec 2004||Unavailable||1 Aug 2014||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Prospective
- Sampling: Non-Probability Sample